This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Janssen Sciences Ireland Uc, Oncodesign Sa. Active years: 2015-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Murica, ES (2015)
- Murcia, ES (2016)
Company Filing History:
Years Active: 2015-2026
Title: Mourad Daoubi Khamlichi: Innovator in Viral Infection Treatments
Introduction
Mourad Daoubi Khamlichi is a notable inventor based in Murcia, Spain. With two patents to his name, Khamlichi has made significant contributions to the field of pharmaceutical innovations, particularly concerning treatments for viral infections.
Latest Patents
Among Mourad Daoubi Khamlichi's most recent inventions are his patents pertaining to piperidino-pyrimidine derivatives. These patents detail processes for the preparation of these compounds, pharmaceutical compositions, and their application in the treatment of viral infections. The repetition of this theme underscores its importance in his work and reflects a focused effort to address critical health challenges.
Career Highlights
Mourad Khamlichi's professional journey has been marked by his role at Janssen Sciences Ireland UC, a company renowned for its commitment to developing innovative treatments in the pharmaceutical industry. His work has led to advancements in therapeutic options available for combating viral infections.
Collaborations
Throughout his career, Khamlichi has collaborated with other talented professionals in the field, including David Craig McGowan and Pierre Jean-Marie Bernard Raboisson. These partnerships have likely enriched his research endeavors, fostering a collaborative spirit in addressing complex medical challenges.
Conclusion
Mourad Daoubi Khamlichi exemplifies the spirit of innovation within the pharmaceutical sector. His contributions, particularly in developing new treatment modalities for viral infections, position him as a key figure in the ongoing quest to improve health outcomes globally. As he continues his work at Janssen Sciences Ireland UC, the impact of his inventions may lead to significant advancements in therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile